Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Collegium Pharma (COLL)

Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,493,936
  • Shares Outstanding, K 31,611
  • Annual Sales, $ 631,450 K
  • Annual Income, $ 69,190 K
  • EBIT $ 154 M
  • EBITDA $ 321 M
  • 60-Month Beta 0.60
  • Price/Sales 2.48
  • Price/Cash Flow 3.75
  • Price/Book 5.31

Options Overview Details

View History
  • Implied Volatility 54.94% (-4.78%)
  • Historical Volatility 24.00%
  • IV Percentile 44%
  • IV Rank 44.64%
  • IV High 81.84% on 10/06/25
  • IV Low 33.26% on 08/18/25
  • Expected Move (DTE 8) 4.21 (8.90%)
  • Put/Call Vol Ratio 0.50
  • Today's Volume 9
  • Volume Avg (30-Day) 19
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 336
  • Open Int (30-Day) 336
  • Expected Range 43.05 to 51.47

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 2.03
  • Number of Estimates 3
  • High Estimate 2.08
  • Low Estimate 2.00
  • Prior Year 1.63
  • Growth Rate Est. (year over year) +24.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
44.51 +6.18%
on 01/05/26
50.79 -6.94%
on 12/29/25
-0.65 (-1.36%)
since 12/05/25
3-Month
31.26 +51.18%
on 10/13/25
50.79 -6.94%
on 12/29/25
+13.87 (+41.54%)
since 10/07/25
52-Week
23.23 +103.44%
on 04/10/25
50.79 -6.94%
on 12/29/25
+18.12 (+62.18%)
since 01/07/25

Most Recent Stories

More News
Collegium Provides 2026 Financial Guidance and Business Update

– Product Revenues, Net Expected in the Range of $805 Million to $825 Million – – Jornay PM ® Net Revenue Expected in the Range of $190 Million to $200 Million – – Adjusted EBITDA*...

COLL : 47.26 (+2.27%)
3 Russell 2000 Stocks Walking a Fine Line

3 Russell 2000 Stocks Walking a Fine Line

COLL : 47.26 (+2.27%)
CVGW : 21.59 (+0.61%)
HCAT : 2.50 (+5.04%)
Collegium Announces the Closing of $980 Million Syndicated Credit Facility

STOUGHTON, Mass., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), today announced the closing of its inaugural syndicated credit facility. The new aggregate $980 million...

COLL : 47.26 (+2.27%)
2 Reasons to Avoid COLL and 1 Stock to Buy Instead

2 Reasons to Avoid COLL and 1 Stock to Buy Instead

COLL : 47.26 (+2.27%)
3 Cash-Producing Stocks We Think Twice About

3 Cash-Producing Stocks We Think Twice About

COLL : 47.26 (+2.27%)
ROCK : 48.56 (-3.84%)
FUBO : 2.50 (unch)
3 Unpopular Stocks We Find Risky

3 Unpopular Stocks We Find Risky

FCN : 176.00 (-0.94%)
COLL : 47.26 (+2.27%)
BK : 120.45 (-0.71%)
Branded Pharmaceuticals Stocks Q3 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL)

Branded Pharmaceuticals Stocks Q3 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL)

COLL : 47.26 (+2.27%)
1 Growth Stock Set to Flourishand 2 Facing Challenges

1 Growth Stock Set to Flourishand 2 Facing Challenges

COLL : 47.26 (+2.27%)
SBCF : 32.36 (-0.55%)
LOB : 35.66 (-1.95%)
1 Mooning Stock with Promising Prospects and 2 Facing Challenges

1 Mooning Stock with Promising Prospects and 2 Facing Challenges

COLL : 47.26 (+2.27%)
IRTC : 187.39 (+1.30%)
FBK : 56.92 (-0.70%)
1 Small-Cap Stock with Exciting Potential and 2 We Avoid

1 Small-Cap Stock with Exciting Potential and 2 We Avoid

COLL : 47.26 (+2.27%)
HIMS : 35.46 (unch)
BOH : 69.71 (-0.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171,...

See More

Key Turning Points

3rd Resistance Point 49.71
2nd Resistance Point 48.69
1st Resistance Point 47.98
Last Price 47.26
1st Support Level 46.25
2nd Support Level 45.23
3rd Support Level 44.52

See More

52-Week High 50.79
Last Price 47.26
Fibonacci 61.8% 40.26
Fibonacci 50% 37.01
Fibonacci 38.2% 33.76
52-Week Low 23.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar